Search
NRP369
go.drugbank.com/drugs/DB06384ExperimentalNRP369 is an oxycodone derivative under investigation for the treatment of pain (moderate to moderately severe). NRP369 was developed by New River Pharmaceuticals as a backup therapeutic to [NRP290].
AVR118
go.drugbank.com/drugs/DB04979Investigationalof cancers); for its ability to stimulate the immune system to attack tumor cells (especially those cancer cells that have been damaged by chemotherapeutic agents) and for its ability to treat cachexia … AVR118 is being studied for the promise shown in its ability to mitigate the toxic side effects of other drugs (including those used to treat HIV infection and chemotherapeutic drugs employed in the treatment
Felis catus skin
go.drugbank.com/drugs/DB10399ApprovedFelis catus skin or pelt is used in allergenic testing.
Sus scrofa skin
go.drugbank.com/drugs/DB10606ApprovedSus scrofa skin or pelt is used in allergenic testing.
Rattus norvegicus skin
go.drugbank.com/drugs/DB10608ApprovedRattus norvegicus skin or pelt is used in allergenic testing.
AZD-7295
go.drugbank.com/drugs/DB12724InvestigationalAZD7295 has been investigated for the treatment of Hepatitis C.
Glyceryl Trioleate
go.drugbank.com/drugs/DB13038InvestigationalGlyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.
Surinabant
go.drugbank.com/drugs/DB13070InvestigationalSurinabant has been investigated for the treatment of Smoking Cessation.
Gisadenafil
go.drugbank.com/drugs/DB11902InvestigationalGisadenafil has been investigated for the treatment of Prostatic Hyperplasia.
Napabucasin
go.drugbank.com/drugs/DB12155InvestigationalNapabucasin has been investigated for the treatment of Colorectal Carcinoma.